Cardiol Therapeutics Inc Ordinary Shares - Class A CRDL 深 滬
等待開盤 10-22 09:30:00 美东时间
1.21
+0.160
+15.24%
華盛通- 最 高1.24
- 今 開1.06
- 成交量 280.56万股
- 最 低 1.05
- 昨 收 1.05
- 總市值 1.01亿
- 52周最高 2.24
- 市盈率 靜 --
- 換手率 3.35%
- 52周最低 0.7709
- 委 比 -78.72%
- 總股本 8372.94万
- 歷史最高 4.96
- 量 比 3.65
- 振 幅 18.10%
- 歷史最低 0.45
- 每 手 1
- 風險率 0.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cardiol Therapeutics Secures $11M Financing, Advances Heart Disease Therapies
The latest announcement is out from Cardiol Therapeutics ( ($TSE:CRDL) ). Cardi...
10-18 05:06
Cordel Group Expands Middle East Contract, Strengthens Rail Safety Services
Cordel Group PLC ( ($GB:CRDL) ) has issued an update. Cordel Group PLC has anno...
10-13 14:21
Cardiol Therapeutics to Present at Canaccord Genuity Conference
Cardiol Therapeutics ( ($TSE:CRDL) ) has shared an announcement. Cardiol Therap...
08-11 20:14
Cardiol Therapeutics Reports Compelling ARCHER Trial Results Supporting Advancement of CardiolRx And CRD-38 in Myocarditis And Heart Failure
Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring CardiolRx™ over placebo.Reduction in ECV was associated with improvements
08-06 19:29
Cardiol Locks Key Trial Data as It Advances New Treatment for Dangerous Heart Inflammation
Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart
07-22 19:33
美股大行评级 | 再生元制药遭大摩下调评级，Aspen Insurance Hldgs(AHL)获多家机构首予“超配”评级！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136585934532136961.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Vera Therapeutics(VERA)"买入"评级，目标价从75美元升至85美元</p> <p>• Ascendiant Capital：维持60 Degrees
06-03 09:06
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
06-02 21:12
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials
The latest update is out from Cardiol Therapeutics ( ($TSE:CRDL) ). Cardiol The...
05-27 19:47
Cordel Group Advances AI-Driven Rail Asset Management
An announcement from Cordel Group PLC ( ($GB:CRDL) ) is now available. Cordel G...
04-09 14:20
美股大行评级 | 潜在涨幅147.43%！HC Wainwright & Co.上调Pacira BioSciences目标价至65美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Pacira BioSciences(PCRX)"买入"评级，目标价从48美元升至65美元</p> <p>• 瑞穗：上调Amylyx Pharmaceuticals(AM
04-09 08:50
